Inventor · disambiguated record
Byung-Heon Lee
Also filed as: LEE BYUNG H · LEE BYUNG-HEON
16 granted patents·10 pending applications·172 citations·filing 1982–2023
91Inventor score
Files withKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND9KYUNGPOOK NAT UNIV IND ACAD6LEE BYUNG-HEON6BELL TELEPHONE LABOR INC1KIM IN-SAN1
Top patents by PatentIndex Score
26 records- 0193US4449238AVoice-actuated switching systemBELL TELEPHONE LABOR INC·Filed 1982·Granted May 15, 1984·120 cites·36 claims
- 0284US7745410B2Bladder tumor-targeting peptide and use thereofKYUNGPOOK NAT UNIV IND ACAD·Filed 2007·Granted Jun 29, 2010·3 cites·8 claims
- 0383US8217012B2Peptides for targeting apoptotic cells and uses thereofLEE BYUNG HEON·Filed 2009·Granted Jul 10, 2012·3 cites·17 claims
- 0482US6650374B2Digital television relay systemLG ELECTRONICS INC·Filed 2000·Granted Nov 18, 2003·30 cites·20 claims
- 0575US8748398B2Stroke-targeting peptide and use thereofLEE BYUNG-HEON·Filed 2009·Granted Jun 10, 2014·3 cites·11 claims
- 0674US7968081B2Peptide for diagnosing, preventing and treating atherosclerosis and uses thereofKYUNGPOOK NAT UNIV IND ACAD·Filed 2008·Granted Jun 28, 2011·3 cites·17 claims
- 0768US7919464B2Use of a peptide that interacts with αvβ3 integrin of endothelial cellKYUNGPOOK NAT UNIV IND ACAD·Filed 2004·Granted Apr 5, 2011·6 cites·10 claims
- 0865US8975369B2Protein skeletal module which increases the binding affinity and binding specificity of active polypeptidesKYUNGPOOK NAT UNIV IND ACAD·Filed 2013·Granted Mar 10, 2015·1 cites·7 claims
- 0963US8900551B2Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereofLEE BYUNG-HEON·Filed 2012·Granted Dec 2, 2014·1 cites·14 claims
- 1063US8133971B2Polypeptide specifically bound to phosphatidylserine and the use thereofLEE BYUNG-HEON·Filed 2009·Granted Mar 13, 2012·2 cites·5 claims
- 1158US2007167369A1Novel use of isolated polypeptide comprising four FAS-1 domains, EM1 domain and RGD motifKYUNGPOOK NAT UNIV IND ACAD·Filed 2007·Application pending·0 cites
- 1258US2025154201A1Peptide binding to mesothelin, and use thereofKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2023·Application pending·0 cites
- 1356US2008274955A1Novel Use of a Polypeptide Comprising Fas-1 DomainKYUNGPOOK NAT UNIV IND ACAD·Filed 2004·Application pending·0 cites
- 1456US2023374113A1Ferritin nanocage fused with pd-l1-binding peptide 1 and use thereof as anticancer immunotherapy agentKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2023·Application pending·0 cites
- 1554US11306119B2Peptide bound to PD-L1 and use thereofKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2018·Granted Apr 19, 2022·0 cites·8 claims
- 1654US11192920B2Peptides for binding to CD44v6 and use thereofKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2018·Granted Dec 7, 2021·0 cites·9 claims
- 1749US2015051269A1Drug Delivery Conjugate Capable of Controlled Release, and Use ThereofPOSTECH ACAD IND FOUND·Filed 2013·Application pending·0 cites
- 1847US2024201172A1Use of odorant receptor for suppressing lactate-induced m2-type differentiation of tumor-associated macrophages and tumor growthKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2022·Application pending·0 cites
- 1946US10370410B2Cancer cell-targeting peptide and use thereofKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2016·Granted Aug 6, 2019·0 cites·10 claims
- 2046US2018201651A1Pharmaceutical composition that is anticancer and suppresses cancer metastasis, containing, as active ingredient, fusion peptide simultaneously targeting cancer cell and tumor associated macrophageKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2017·Application pending·0 cites
- 2146US2023295229A1Peptide selectively binding to cancer cell-derived exosome, and uses thereofKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2021·Application pending·0 cites
- 2245US2012258038A1Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseasesLEE BYUNG-HEON·Filed 2012·Application pending·0 cites
- 2340US8993721B2Peptides for targeting apoptotic cells and uses thereofLEE BYUNG HEON·Filed 2012·Granted Mar 31, 2015·0 cites·15 claims
- 2436US10421780B2Peptide for targeting autophagic cells and use thereofKYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND·Filed 2017·Granted Sep 24, 2019·0 cites·5 claims
- 2535US9833464B2Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereofKIM IN SAN·Filed 2010·Granted Dec 5, 2017·0 cites·7 claims
- 2633US2017340698A1Cyclic peptide specifically binding to apoptotic cells and use thereofKYUNGPOOK NATIONAL UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Byung-Heon Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →